Skip to main content
. 2016 Mar;101(3):346–355. doi: 10.3324/haematol.2015.135780

Table 3.

Patients with bortezomib-refractory multiple myeloma treated in the extension cohort of the trial. Overview of the disease characteristics, response to prior therapies, number of treatment cycles and response achieved on an individual patient basis.

graphic file with name 101346.tab3.jpg